4.6 Article

Interpreting differences in patterns of supportive care needs between patients with breast cancer and patients with colorectal cancer

Journal

PSYCHO-ONCOLOGY
Volume 22, Issue 4, Pages 792-798

Publisher

WILEY
DOI: 10.1002/pon.3068

Keywords

supportive care; breast cancer; colorectal cancer; Chinese; perceived need; oncology

Ask authors/readers for more resources

Background Understanding cancer patients' supportive care needs can help optimize health-care systems and inform services development. We therefore examined the prevalence of supportive care needs in Chinese breast (BC) and colorectal cancer (CRC) patients to identify prevalence and correlates of unmet needs. Methods We assessed supportive care needs (Supportive Care Needs SurveyShort Form), psychological distress (the Hospital Anxiety and Depression Scale), symptom distress (The Memorial Symptom Assessment ScaleShort Form), and satisfaction with care (Patient Satisfaction Questionnaire) among 210 Chinese BC (97) or CRC (104) outpatient clinic attendees. Results Breast cancer patients (89.7%) reported more unmet needs (2=4.409, p=0.027), but both CRC and BC samples ranked unmet needs prevalence similarly, with health system and information needs reported as the most common. Younger patients reported higher health system and information and sexuality needs. After multivariate adjustment, the strength of unmet needs did not differ by cancer type. Unmet psychological, physical and daily living, and sexuality needs were positively associated with greater symptom distress. Greater health system information needs were associated with high global distress and low depression scores, whereas greater psychological needs were associated with higher anxiety scores. Conclusions Hong Kong Chinese BC and CRC patients strongly prioritized needs related to health systems and information provision. Symptoms and psychological distress were associated with unmet needs, reflecting a service shortfall in symptom management. Improving care provision by optimizing communication and clinic organization can better prepare cancer patients for their rehabilitation and improve symptom control. Copyright (c) 2012 John Wiley & Sons, Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Risk perception, treatment adherence, and personality during COVID-19 pandemic: An international study on cancer patients

Simone Cheli, Wendy W. T. Lam, Tania Estape, Jeanette Winterling, Ozan Bahcivan, Elisabeth Andritsch, Joachim Weis, Isabel Centeno, Samantha Serpentini, Clemens Farkas, Yvonne Wengstrom, Luisa Fioretto, Lea Baider, Cherry C. L. Lam, Gil Goldzweig

Summary: This study investigates the role of personality traits in moderating the relationship between COVID-19 risk perception and treatment adherence, and between risk perception and psychosocial distress in cancer patients. The results suggest that personality traits may influence how patients adjust to cancer treatment and other highly stressful events, such as the COVID-19 pandemic. Further research is needed to confirm these findings in different cancer stages and types.

PSYCHO-ONCOLOGY (2022)

Article Oncology

A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer

Sherko Kuemmel, Mario Campone, Delphine Loirat, Rafael Lopez Lopez, J. Thaddeus Beck, Michelino De Laurentiis, Seock-Ah Im, Sung-Bae Kim, Ava Kwong, Guenther G. Steger, Esther Zamora Adelantado, Francois P. Duhoux, Richard Greil, Irene Kuter, Yen-Shen Lu, Ariadna Tibau, Mustafa Ozguroglu, Christian W. Scholz, Christian F. Singer, Estela Vega, Pauline Wimberger, Claudio Zamagni, Xuan-Mai Couillebault, Liqiong Fan, Nelson Guerreiro, Jennifer Mataraza, Janna Sand-Dejmek, Arlene Chan

Summary: This phase II study aimed to evaluate the efficacy of lacnotuzumab added to gemcitabine plus carboplatin in patients with advanced triple-negative breast cancer. The results showed that lacnotuzumab + gem-carbo had comparable antitumor activity to gem-carbo alone, but with slightly poorer tolerability.

CLINICAL CANCER RESEARCH (2022)

Article Biochemistry & Molecular Biology

Polygenic risk modeling for prediction of epithelial ovarian cancer risk

Eileen O. Dareng, Jonathan P. Tyrer, Daniel R. Barnes, Michelle R. Jones, Xin Yang, Katja K. H. Aben, Muriel A. Adank, Simona Agata, Irene L. Andrulis, Hoda Anton-Culver, Natalia N. Antonenkova, Gerasimos Aravantinos, Banu K. Arun, Annelie Augustinsson, Judith Balmana, Elisa Bandera, Rosa B. Barkardottir, Daniel Barrowdale, Matthias W. Beckmann, Alicia Beeghly-Fadiel, Javier Benitez, Marina Bermisheva, Marcus Q. Bernardini, Line Bjorge, Amanda Black, Natalia Bogdanova, Bernardo Bonanni, Ake Borg, James D. Brenton, Agnieszka Budzilowska, Ralf Butzow, Saundra S. Buys, Hui Cai, Maria A. Caligo, Ian Campbell, Rikki Cannioto, Hayley Cassingham, Jenny Chang-Claude, Stephen J. Chanock, Kexin Chen, Yoke-Eng Chiew, Wendy K. Chung, Kathleen B. M. Claes, Sarah Colonna, Linda S. Cook, Fergus J. Couch, Mary B. Daly, Fanny Dao, Eleanor Davies, Miguel de la Hoya, Robin de Putter, Joe Dennis, Allison DePersia, Peter Devilee, Orland Diez, Yuan Chun Ding, Jennifer A. Doherty, Susan M. Domchek, Thilo Dork, Andreas du Bois, Matthias Durst, Diana M. Eccles, Heather A. Eliassen, Christoph Engel, Gareth D. Evans, Peter A. Fasching, James M. Flanagan, ReneeT Fortner, Eva Machackova, Eitan Friedman, Patricia A. Ganz, Judy Garber, Francesca Gensini, Graham G. Giles, Gord Glendon, Andrew K. Godwin, Marc T. Goodman, Mark H. Greene, Jacek Gronwald, Opal Study Group, AOCSGroup, Eric Hahnen, Christopher A. Haiman, Niclas Hakansson, Ute Hamann, Thomas V. O. Hansen, Holly R. Harris, Mikael Hartman, Florian Heitz, Michelle A. T. Hildebrandt, Estrid Hogdall, Claus K. Hogdall, John L. Hopper, Ruea-Yea Huang, Chad Huff, Peter J. Hulick, David G. Huntsman, Evgeny N. Imyanitov, Claudine Isaacs, Anna Jakubowska, Paul A. James, Ramunas Janavicius, Allan Jensen, Oskar Th Johannsson, Esther M. John, Michael E. Jones, Daehee Kang, Beth Y. Karlan, Anthony Karnezis, Linda E. Kelemen, Elza Khusnutdinova, Lambertus A. Kiemeney, Byoung-Gie Kim, Susanne K. Kjaer, Ian Komenaka, Jolanta Kupryjanczyk, Allison W. Kurian, Ava Kwong, Diether Lambrechts, Melissa C. Larson, Conxi Lazaro, Nhu D. Le, Goska Leslie, Jenny Lester, Fabienne Lesueur, Douglas A. Levine, Lian Li, Jingmei Li, Jennifer T. Loud, Karen H. Lu, Phuong L. Mai, Siranoush Manoukian, Jeffrey R. Marks, Rayna KimMatsuno, Keitaro Matsuo, Taymaa May, Lesley McGuffog, John R. McLaughlin, Iain A. McNeish, Noura Mebirouk, Usha Menon, Austin Miller, Roger L. Milne, Albina Minlikeeva, Francesmary Modugno, Marco Montagna, Kirsten B. Moysich, Elizabeth Munro, Katherine L. Nathanson, Susan L. Neuhausen, Heli Nevanlinna, Joanne Ngeow Yuen Yie, Henriette Roed Nielsen, Finn C. Nielsen, Liene Nikitina-Zake, Kunle Odunsi, Kenneth Offit, Edith Olah, Siel Olbrecht, Olufunmilayo Olopade, Sara H. Olson, Hakan Olsson, Ana Osorio, Laura Papi, Sue K. Park, Michael T. Parsons, Harsha Pathak, Inge Sokilde Pedersen, Ana Peixoto, Tanja Pejovic, Pedro Perez-Segura, Jennifer B. Permuth, Beth Peshkin, Paolo Peterlongo, Anna Piskorz, Darya Prokofyeva, Paolo Radice, Johanna Rantala, Marjorie J. Riggan, Harvey A. Risch, Cristina Rodriguez-Antona, Eric Ross, Mary Anne Rossing, Ingo Runnebaum, Dale P. Sandler, Marta Santamarina, Penny Soucy, Rita K. Schmutzler, V. Wendy Setiawan, Kang Shan, Weiva Sieh, Jacques Simard, Christian F. Singer, Anna P. Sokolenko, Honglin Song, Melissa C. Southey, Helen Steed, Dominique Stoppa-Lyonnet, Rebecca Sutphen, Anthony J. Swerdlow, Yen Yen Tan, Manuel R. Teixeira, Soo Hwang Teo, Kathryn L. Terry, Mary BethTerry, Mads Thomassen, Pamela J. Thompson, Liv Cecilie Vestrheim Thomsen, Darcy L. Thull, Marc Tischkowitz, Linda Titus, Amanda E. Toland, Diana Torres, Britton Trabert, Ruth Travis, Nadine Tung, Shelley S. Tworoger, Ellen Valen, Anne M. van Altena, Annemieke H. van der Hout, ElsVan Nieuwenhuysen, Elizabeth J. van Rensburg, Ana Vega, Digna Velez Edwards, Robert A. Vierkant, Frances Wang, Barbara Wappenschmidt, Penelope M. Webb, Clarice R. Weinberg, Jeffrey N. Weitzel, Nicolas Wentzensen, Emily White, Alice S. Whittemore, Stacey J. Winham, Alicja Wolk, Yin-Ling Woo, Anna H. Wu, Li Yan, Drakoulis Yannoukakos, Katia M. Zavaglia, Wei Zheng, Argyrios Ziogas, Kristin K. Zorn, Zdenek Kleibl, Douglas Easton, Kate Lawrenson, Anna DeFazio, Thomas A. Sellers, Susan J. Ramus, Celeste L. Pearce, Alvaro N. Monteiro, Julie Cunningham, Ellen L. Goode, Joellen M. Schildkraut, Andrew Berchuck, Georgia Chenevix-Trench, Simon A. Gayther, Antonis C. Antoniou, Paul D. P. Pharoah

Summary: This study developed polygenic risk score models for risk prediction of epithelial non-mucinous ovarian cancer and validated their predictive value in diverse populations and BRCA1/BRCA2 mutation carriers, suggesting potential clinical utility in ovarian cancer prevention programs.

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

Article Genetics & Heredity

Polygenic risk scores for prediction of breast cancer risk in Asian populations

Weang-Kee Ho, Mei-Chee Tai, Joe Dennis, Xiang Shu, Jingmei Li, Peh Joo Ho, Iona Y. Millwood, Kuang Lin, Yon-Ho Jee, Su-Hyun Lee, Nasim Mavaddat, Manjeet K. Bolla, Qin Wang, Kyriaki Michailidou, Jirong Long, Eldarina Azfar Wijaya, Tiara Hassan, Kartini Rahmat, Veronique Kiak Mien Tan, Benita Kiat Tee Tan, Su Ming Tan, Ern Yu Tan, Swee Ho Lim, Yu-Tang Gao, Ying Zheng, Daehee Kang, Ji-Yeob Choi, Wonshik Han, Han-Byoel Lee, Michiki Kubo, Yukinori Okada, Shinichi Namba, Sue K. Park, Sung-Won Kim, Chen-Yang Shen, Pei-Ei Wu, Boyoung Park, Kenneth R. Muir, Artitaya Lophatananon, Anna H. Wu, Chiu-Chen Tseng, Keitaro Matsuo, Hidemi Ito, Ava Kwong, Tsun L. Chan, Esther M. John, Allison W. Kurian, Motoki Iwasaki, Taiki Yamaji, Sun-Seog Kweon, Kristan J. Aronson, Rachel A. Murphy, Woon-Puay Koh, Chiea-Chuen Khor, Jian-Min Yuan, Rajkumar Dorajoo, Robin G. Walters, Zhengming Chen, Liming Li, Jun Lv, Keum-Ji Jung, Peter Kraft, Paul D. B. Pharoah, Alison M. Dunning, Jacques Simard, Xiao-Ou Shu, Cheng-Har Yip, Nur Aishah Mohd Taib, Antonis C. Antoniou, Wei Zheng, Mikael Hartman, Douglas F. Easton, Soo-Hwang Teo

Summary: This study developed breast cancer polygenic risk scores (PRSs) using data from Asian populations and evaluated their transferability across different ethnic subgroups. The results showed that the combined Asian and European PRSs had the best performance in stratifying the breast cancer risk for women of Asian ancestry.

GENETICS IN MEDICINE (2022)

Review Oncology

What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis

Yvonne L. Luigjes-Huizer, Nina M. Tauber, Gerry Humphris, Nadine A. Kasparian, Wendy W. T. Lam, Sophie Lebel, Sebastien Simard, Allan Ben Smith, Robert Zachariae, Yati Afiyanti, Katy J. L. Bell, Jose A. E. Custers, Niek J. de Wit, Peter L. Fisher, Jacqueline Galica, Sheila N. Garland, Charles W. Helsper, Mette M. Jeppesen, Jianlin Liu, Roxana Mititelu, Evelyn M. Monninkhof, Lahiru Russell, Josee Savard, Anne E. M. Speckens, Sanne J. van Helmondt, Sina Vatandoust, Nicholas Zdenkowski, Marije L. van der Lee

Summary: Objective Care for fear of cancer recurrence (FCR) is the most common unmet need among cancer survivors. This study provides a comprehensive overview of the prevalence and severity of FCR among cancer survivors and patients, and reveals the associations between FCR and clinical and demographic characteristics. The findings emphasize the importance of addressing FCR and providing treatment to those in need.

PSYCHO-ONCOLOGY (2022)

Article Oncology

International collaboration for assessing unmet needs of cancer survivors and family caregivers: Lens of healthcare professionals

Youngmee Kim, Amanda Ting, Charles S. Carver, Ozan Bahcivan, Cristiane Decat Bergerot, Degi Csaba, Tania Estape, Daisuke Fujisawa, Savita S. Goswami, Wendy Wing Tak Lam, Andrada Parvu, Eun-Jung Shim, Samantha Serpentini, Emi Takeuchi, Ashley Wang

Summary: This study aimed to evaluate healthcare professionals' assessment of unmet needs of cancer patients and family caregivers globally. The results showed that emotional distress and medical care needs were the most common concerns, yet less than two-thirds of healthcare professionals reported that their institutions provided services or programs to meet these needs.

PSYCHO-ONCOLOGY (2023)

Article Oncology

Delayed Sentinel Lymph Node Dissection in Patients with a Preoperative Diagnosis of Ductal Cancer In Situ by Preoperative Injection with Superparamagnetic Iron Oxide (SPIO) Nanoparticles: The SentiNot Study

Andreas Karakatsanis, Staffan Eriksson, Lida Pistiolis, Roger Olofsson Bagge, Gyula Nagy, Vivian Man, Ava Kwong, Fredrik Warnberg

Summary: This study demonstrates that marking the SLN with SPIO can avoid overtreatment and allow for accurate d-SLND in patients with DCIS. This is significant for the treatment of patients with DCIS.

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Oncology

Prospective Clinical Trial on Expanding Indications for Cryosurgery for Early Breast Cancers

Ava Kwong, Michael Co, Eisuke Fukuma

Summary: This study is a prospective single-arm clinical trial on cryosurgery for early breast cancers, evaluating the expanded criteria for tumors larger than 1.5 cm and non-luminal breast cancers. The results showed that residual cancer was found in 46.7% of patients, all of which were located at the periphery of the cryoablation zone. Careful pre-operative planning and intra-operative monitoring are crucial to ensure complete cryoablation.

CLINICAL BREAST CANCER (2023)

Article Medicine, General & Internal

Study protocol of ConquerFear-HK: a randomised controlled trial of a metacognition-based, manualised intervention for fear of cancer recurrence among Chinese cancer survivors

Danielle Wing Lam Ng, Richard Fielding, Catherine Tsang, Carmen Ng, Joyce Chan, Amy Or, Izy Wing Man Kong, Julia Wei Chun Tang, Wylie Wai Yee Li, Amy Tien Yee Chang, Chi Choo Foo, Ava Kwong, Simon Siu-Man Ng, Dacita Suen, Miranda Chan, Oi-Kwan Chun, Karen Kar Loen Chan, Phyllis N. Butow, Wendy Wing Tak Lam

Summary: The purpose of this study is to evaluate the effectiveness of the Chinese version of the ConquerFear-HK intervention in improving fear of cancer recurrence. A randomized controlled trial will be conducted with 174 eligible Chinese cancer survivors who will be assigned to either the ConquerFear-HK or BasicCancerCare intervention. Various measures will be used to assess the intervention's effects and psychological impacts.

BMJ OPEN (2023)

Article Oncology

Use of Superparamagnetic Iron Oxide (SPIO) Versus Conventional Technique in Sentinel Lymph Node Detection for Breast Cancer: A Randomised Controlled Trial

Vivian Man, Dacita Suen, Ava Kwong

Summary: The study compares the efficacy of superparamagnetic iron oxide (SPIO)-guided and standard techniques for detecting sentinel lymph nodes (SLN) in early breast cancer. Multiple inferiority trials have shown that SPIO is not inferior to conventional techniques in detecting SLNs. The results indicate that single-tracer SPIO-guided SLNB is as effective as the dual technique (radioisotope and blue dye) and can safely replace the gold standard for SLN mapping in early breast cancer.

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Clinical Neurology

Trajectories of sleep disturbance in cancer survivors during the first 2 years post-treatment

Julia Chan, Danielle Wing Lam Ng, Qiuyan Liao, Richard Fielding, Inda Soong, Karen Kar Loen Chan, Conrad Lee, Alice Wan Ying Ng, Wing Kin Sze, Wing Lok Chan, Victor Ho Fun Lee, Wendy Wing Tak Lam

Summary: The study aims to examine the trajectories of sleep disturbance in cancer survivors during the first 2 years post-treatment and to investigate whether psychological, cognitive, and physical factors differentiate these trajectories. The findings showed that one in three cancer survivors experienced persistent high sleep disturbance, with higher rates of intrusive thoughts and cancer-related hyperarousal compared to stable good sleepers. Higher depression scores also predicted membership in the persistent high sleep disturbance group.

SLEEP (2023)

Article Oncology

Effect on Germline Mutation Rate in a High-Risk Chinese Breast Cancer Cohort after Compliance with The National Comprehensive Cancer Network (NCCN) 2023 v.1 Testing Criteria

Ava Kwong, Cecilia Y. S. Ho, Wing-Pan Luk, Ling-Hiu Fung, Chun-Hang Au, Edmond S. K. Ma

Summary: A study in the Chinese population found that the updated NCCN guidelines for the testing of breast cancer susceptibility genes had a positive effect on the detection rate of germline mutations. However, there is a need to carefully consider the balance between resources and outcomes.

CANCERS (2023)

Article Oncology

Implementing a nurse-led screening clinic for symptom distress with community-based referral for cancer survivors: A feasibility study

Wendy Wing Tak Lam, Danielle W. L. Ng, Richard Fielding, Vivian Sin, Catherine Tsang, Wendy W. L. Chan, Chi Chung Foo, Ava Kwong, Karen K. L. Chan

Summary: This study evaluated the feasibility of a nurse-led symptom-screening program in routine oncology post-treatment outpatient clinics. The results showed that this program was acceptable and effective in reducing symptom distress, with a high acceptance rate for community-based psychosocial support services.

PSYCHO-ONCOLOGY (2023)

Article Oncology

A dyadic examination of patients' and caregivers' attachment orientations and mutually supportive care in cancer caregiving

Christine J. McPherson, Alanna Devereaux

Summary: This study examines the dyadic effects of patient and caregiver attachment orientations on mutually supportive care in cancer treatment. It highlights the interdependence within the cancer caregiving relationship and emphasizes the importance of considering individual and relational ways of responding in providing support. Attachment theory provides a framework for understanding and therapeutic intervention.

PSYCHO-ONCOLOGY (2024)